Company registration number 10600086 (England and Wales)
SOUTH TYNESIDE HEALTH COLLABORATION LTD
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
PAGES FOR FILING WITH REGISTRAR
SOUTH TYNESIDE HEALTH COLLABORATION LTD
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
The following pages do not form part of the statutory financial statements
Detailed profit and loss account
-
SOUTH TYNESIDE HEALTH COLLABORATION LTD
BALANCE SHEET
AS AT
31 MARCH 2026
31 March 2026
- 1 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
3
126,527
6,316
Current assets
Debtors
4
1,970,012
1,649,369
Cash at bank and in hand
2,174,607
1,959,288
4,144,619
3,608,657
Creditors: amounts falling due within one year
5
(3,829,079)
(3,262,313)
Net current assets
315,540
346,344
Total assets less current liabilities
442,067
352,660
Provisions for liabilities
(15,635)
-
Net assets
426,432
352,660
Capital and reserves
Called up share capital
6
1,253
1,255
Capital redemption reserve
7
2
-
0
Profit and loss reserves
7
425,177
351,405
Total equity
426,432
352,660

For the financial year ended 31 March 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 9 July 2026 and are signed on its behalf by:
Mrs T A Burrell
Director
Company registration number 10600086 (England and Wales)
SOUTH TYNESIDE HEALTH COLLABORATION LTD
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026
- 2 -
1
Accounting policies
Company information

South Tyneside Health Collaboration Ltd is a private company limited by shares incorporated in England and Wales. The registered office is Stanhope Parade Health Centre, Gordon Street, South Shields, NE33 4JP.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue represents amounts receivable for general medical practice activities. Revenue is attributable to the continuing principal activity of the company and arose wholly within the United Kingdom.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Fixtures and fittings
33% straight line
Computer equipment
33% straight line

During the year, the depreciation rate for fixtures and fittings changed from 15% reducing balance to 33% straight line as the directors believe this is a more accurate basis of depreciation based on the useful life of the assets. Overall, this has resulted in an extra £11,510 of depreciation charged.

1.4
Impairment of fixed assets

At each reporting period end date, the company reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.

1.5
Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

SOUTH TYNESIDE HEALTH COLLABORATION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
1
Accounting policies
(Continued)
- 3 -
Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

1.7
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.8
Employee benefits

The costs of short-term employee benefits, including holiday pay and other similar non-monetary benefits are recognised as an expense in the period in which the service is received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

Past and present employees are covered by the provisions of the NHS Pension Scheme. The scheme is an unfunded, defined benefit scheme that covers NHS employers, GP practices and other bodies, allowed under the direction of the Secretary of State, in England and Wales. The scheme is not designed to be run in a way that would enable NHS bodies to identify their share of the underlying scheme assets and liabilities. Therefore, the scheme is accounted for as if it were a defined contribution scheme: the cost to the NHS Body of participating in the scheme is taken as equal to the contributions payable to the scheme for the accounting period.

SOUTH TYNESIDE HEALTH COLLABORATION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 4 -
2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2026
2025
Total
109
130
3
Tangible fixed assets
Fixtures and fittings
Computer equipment
Total
£
£
£
Cost
At 1 April 2025
11,747
41,025
52,772
Additions
136,213
21,418
157,631
At 31 March 2026
147,960
62,443
210,403
Depreciation and impairment
At 1 April 2025
5,800
40,656
46,456
Depreciation charged in the year
32,835
4,585
37,420
At 31 March 2026
38,635
45,241
83,876
Carrying amount
At 31 March 2026
109,325
17,202
126,527
At 31 March 2025
5,947
369
6,316
4
Debtors
2026
2025
Amounts falling due within one year:
£
£
Trade debtors
1,879,887
1,506,743
Corporation tax recoverable
-
0
22,420
Other debtors
90,125
120,206
1,970,012
1,649,369
5
Creditors: amounts falling due within one year
2026
2025
£
£
Trade creditors
136,096
369,032
Taxation and social security
86,020
83,274
Other creditors
3,606,963
2,810,007
3,829,079
3,262,313
SOUTH TYNESIDE HEALTH COLLABORATION LTD
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2026
- 5 -
6
Called up share capital
2026
2025
Ordinary share capital
£
£
Issued and fully paid
31 ordinary A shares of £1 each
31
33
122,163 ordindary B shares of 1p each
1,222
1,222
1,253
1,255

During the year, the company redeemed 2 ordinary A shares.

7
Reserves
Capital redemption reserve

The capital redemption reserve arose from the redemption of 2 ordinary A shares on March 2026 and it is not distributable.

2026-03-31 2025-04-01 false false false 09 July 2026 CCH Software CCH Accounts Production 2026.100 No description of principal activity Miss T S Roberts Mr L Cramman Mrs T A Burrell Dr J H Lloyd Dr D E Power Dr Z S M Ramzi 10600086 2025-04-01 2026-03-31 10600086 2026-03-31 10600086 2025-03-31 10600086 core:FurnitureFittings 2026-03-31 10600086 core:ComputerEquipment 2026-03-31 10600086 core:FurnitureFittings 2025-03-31 10600086 core:ComputerEquipment 2025-03-31 10600086 core:CurrentFinancialInstruments core:WithinOneYear 2026-03-31 10600086 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 10600086 core:CurrentFinancialInstruments 2026-03-31 10600086 core:CurrentFinancialInstruments 2025-03-31 10600086 core:ShareCapital 2026-03-31 10600086 core:ShareCapital 2025-03-31 10600086 core:CapitalRedemptionReserve 2026-03-31 10600086 core:CapitalRedemptionReserve 2025-03-31 10600086 core:RetainedEarningsAccumulatedLosses 2026-03-31 10600086 core:RetainedEarningsAccumulatedLosses 2025-03-31 10600086 core:ShareCapitalOrdinaryShareClass2 2026-03-31 10600086 core:ShareCapitalOrdinaryShareClass2 2025-03-31 10600086 core:ShareCapitalOrdinaryShareClass3 2026-03-31 10600086 core:ShareCapitalOrdinaryShareClass3 2025-03-31 10600086 core:ShareCapitalOrdinaryShares 2026-03-31 10600086 core:ShareCapitalOrdinaryShares 2025-03-31 10600086 bus:Director3 2025-04-01 2026-03-31 10600086 core:FurnitureFittings 2025-04-01 2026-03-31 10600086 core:ComputerEquipment 2025-04-01 2026-03-31 10600086 2024-04-01 2025-03-31 10600086 core:FurnitureFittings 2025-03-31 10600086 core:ComputerEquipment 2025-03-31 10600086 2025-03-31 10600086 bus:OrdinaryShareClass2 2025-04-01 2026-03-31 10600086 bus:OrdinaryShareClass3 2025-04-01 2026-03-31 10600086 bus:PrivateLimitedCompanyLtd 2025-04-01 2026-03-31 10600086 bus:SmallCompaniesRegimeForAccounts 2025-04-01 2026-03-31 10600086 bus:FRS102 2025-04-01 2026-03-31 10600086 bus:AuditExemptWithAccountantsReport 2025-04-01 2026-03-31 10600086 bus:Director1 2025-04-01 2026-03-31 10600086 bus:Director2 2025-04-01 2026-03-31 10600086 bus:Director4 2025-04-01 2026-03-31 10600086 bus:Director5 2025-04-01 2026-03-31 10600086 bus:Director6 2025-04-01 2026-03-31 10600086 bus:FullAccounts 2025-04-01 2026-03-31 xbrli:pure xbrli:shares iso4217:GBP